SCHEMBL3660083

SCHEMBL3660083

O=C(O)c1ccc(C(=O)Nc2ccc3ccccc3c2)cc1

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 12/20 0.74
RAB9A P51151 12/20 0.74
MEN1 O00255 8/20 0.74
KMT2A Q03164 8/20 0.74
TDP1 Q9NUW8 2/20 0.74
FFAR1 O14842 1/20 0.63
DEGS1 O15121 1/20 0.62
CASP3 P42574 3/20 0.61
SENP7 Q9BQF6 3/20 0.61
SENP6 Q9GZR1 2/20 0.61
L3MBTL1 Q9Y468 1/20 0.61
KDM4E B2RXH2 1/20 0.61
SENP8 Q96LD8 1/20 0.61
NQO2 P16083 1/20 0.61
ALDH1A1 P00352 1/20 0.60
SMN1; SMN2 Q16637 1/20 0.60
F2 P00734 1/20 0.60
PLG P00747 1/20 0.60
PLAU P00749 1/20 0.60
KLKB1 P03952 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3503370 0.93 NPC1 (0.84) NPC1RAB9AMEN1KMT2ATDP1
SCHEMBL2229842 0.91 NPC1 (0.76) NPC1RAB9AMEN1KMT2ATDP1
SCHEMBL3656661 0.90 DEGS1 (0.77) NPC1RAB9AMEN1KMT2ATDP1
SCHEMBL26885202 0.88 NPC1 (0.77) NPC1RAB9AMEN1KMT2ATDP1
SCHEMBL26885197 0.87 PTPN1 (0.73) NPC1RAB9AMEN1KMT2ATDP1
SCHEMBL8081011 0.87 DEGS1 (0.82) NPC1RAB9AMEN1KMT2ATDP1
SCHEMBL26885648 0.86 DEGS1 (0.70) NPC1RAB9AMEN1KMT2ATDP1
SCHEMBL2681024 0.85 NPC1 (1.00) NPC1RAB9AMEN1KMT2ATDP1
SCHEMBL8420152 0.85 NPC1 (0.72) NPC1RAB9AMEN1KMT2ATDP1
SCHEMBL2230642 0.85 NPC1 (0.77) NPC1RAB9AMEN1KMT2ATDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9364424-B2 Topical cosmetic skin lightening compositions and methods of use thereof STIEFEL LABORATORIES, INC. (US) 2016-06-14 US disclosed
US-20160074315-A1 TOPICAL COSMETIC SKIN LIGHTENING COMPOSITIONS AND METHODS OF USE THEREOF STIEFEL LABORATORIES, INC. 2016-03-17 US disclosed
EP-2219600-A1 TOPICAL COSMETIC SKIN LIGHTENING COMPOSITIONS AND METHODS OF USE THEREOF STIEFEL LABORATORIES, INC. (US) 2010-08-25 EP disclosed
WO-2009067095-A1 TOPICAL COSMETIC SKIN LIGHTENING COMPOSITIONS AND METHODS OF USE THEREOF STIEFEL LABORATORIES, INC. (US) 2009-05-28 WO disclosed
EP-1602354-B1 Use of polyglutamic acid or its salts MEIJI SEIKA KAISHA (JP) 2008-11-05 EP disclosed
EP-1604647-B1 Cosmetic composition containing polyorganosiloxane-containing epsilon-polylysine polymer, and polyhydric alcohol, and production thereof CHISSO CORP (JP) 2008-05-07 EP disclosed
US-20060165636-A1 Hair treatment composition and hair cosmetic for damaged hair MEIJI SEIKA KAISHA, LTD. (JP) 2006-07-27 US disclosed
US-20060018867-A1 Cosmetic composition and production thereof ICHIMARU PHARCOS CO., LTD 2006-01-26 US disclosed
EP-1604647-A1 Cosmetic composition containing polyorganosiloxane-containing epsilon-polylysine polymer, and polyhydric alcohol, and production thereof Ichimaru Pharcos Co., Ltd. (JP) 2005-12-14 EP disclosed
EP-1602354-A1 HAIR TREATMENT COMPOSITION AND HAIR COSMETIC FOR DAMAGED HAIR Meiji Seika Kaisha, Ltd. (JP) 2005-12-07 EP disclosed
US-5364912-A Anisotropic melts, reaction of glycidyl ester of dicarboxylic acid and diol or dicarboxylic acid THE DOW CHEMICAL COMPANY (US) 1994-11-15 US disclosed
EP-0475238-A2 Mesogenic glycidyl esters THE DOW CHEMICAL COMPANY (US) 1992-03-18 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060165636-A1 Hair treatment composition and hair cosmetic for damaged hair CUTA, COL14A1, PRKDC NPC1 4845/4885RAB9A 3880/4885MEN1 2813/4885
US-20060018867-A1 Cosmetic composition and production thereof CUTA, PARG, TYR NPC1 3666/4885RAB9A 1846/4885MEN1 1028/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.